| Position | Action |
|---|---|
| Push back toward $196 (upper Bollinger band rejection) | Trim 10-15% |
| Hard stop at $170 (50 SMA, daily close, ~2x ATR buffer) | Exit remaining position |
| VWMA zone $177-180 | Scale in 25-30% of intended size, staged over 3-5 sessions |
| Confirmed close above $203 on volume >12M shares | Full add |
| Flush to $154-160 with heavy volume | Aggressive accumulation |
| Above $187 before Q2 FY27 earnings | No new capital deployed |
When a world-class franchise gets dragged down by sector contagion and trades at a Forward P/E of 12 with a PEG of 0.76, that's not a warning sign — that's a gift.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 183.37 | bullish |
| close_50_sma | 171.74 | bullish |
| close_200_sma | 203.16 | bearish |
| rsi | 58.91 | neutral |
| macd | 5.87 | bullish |
| boll_ub | 196.23 | neutral |
| atr | 8.30 | neutral |
| vwma | 177.25 | bullish |
Support: 177.25 · 171.74 · 154.26 | Resistance: 196.23 · 203.16
CRM technicals show a mixed but constructive picture: short- and intermediate-term trends are bullish (price above 10 EMA and 50 SMA, MACD positive with histogram +2.08, RSI mid-range at 58.91), but the stock remains below the 200 SMA (203.16), confirming a counter-trend recovery within a larger bearish structure. The 8/5 high of 192.98 tested the upper Bollinger band (196.23) and failed, suggesting a 3–7 day consolidation is likely. ATR of 8.30 indicates elevated volatility (~4.4% daily range), warranting wider stops; a 1.5–2× ATR stop from entry maps to $170–$174 near the 50 SMA. VWMA has risen from ~156.6 to 177.25, confirming real accumulation. Key levels: resistance at $196 and $203; support at VWMA ($177), 50 SMA ($172), and lower band ($154). Final recommendation: HOLD existing longs with stop at $170; avoid new full-size longs until the 200 SMA is reclaimed or a deeper dip to $176–$180 provides better entry.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain core CRM position at neutral weight; trim 10-15% into $196 resistance, scale in at $177-180 VWMA zone
Hold existing core exposure. The bull's long-term thesis is plausible and may ultimately force a re-rating post-Q2 FY27 if revenue sustains ≥13% YoY, operating margin holds at ≥21%, and AI revenue gets disclosed as a distinct line item. The bear's tactical caution is correct for today. The neutral's synthesis captures the asymmetric opportunity without burning optionality on event risk the macro and sector tape have stacked into the next 2-3 weeks (Friday's jobs print, Hormuz oil spike, Fed 88% no-cut probability, application-software sector rotation). Position sizing at half of what aggressive proposed because the leveraged buyback has structurally raised equity sensitivity to operating outcomes regardless of the headline 1.15 beta.
When: Confirmed close above $203 on volume >12M shares
Then: Full add to position
Revenue is re-accelerating from 9.8% to 13.3% YoY with best-in-class SaaS margins and elite free cash flow generation, yet the stock trades like a company in terminal decline.
↩ rebuts: “Bear narrative based on sector sell-off and technical weakness”
· concedes: Bad news is priced in — forward P/E of 12 doesn't exist on a company that's actually dying; The 200 SMA at $203 is overhead resistance and the stock must reclaim it to confirm the bull case; The 50 SMA at $171.74 is the operative dynamic support level; Goodwill impairments are non-cash but goodwill of $59B represents intangible risk if acquisitions underperform; ServiceNow is down 23% YTD — the entire application software space got hammered by AI-displacement fears; Figma doubled opex on AI, showing AI costs can be material in the sector; Fed not cutting (88% odds of no cuts) is a headwind already in the price, though Polymarket probability has drifted -1.4pp WoW
CRM's forward multiple is built on consensus estimates that require 80% earnings growth and ignore leverage risk from $41.88B total debt, negative tangible book value, and AI cost pressures that are already showing on the income statement.
· concedes: Technical structure has improved from June lows; Short-term moving averages (10 EMA > 50 SMA > price) are stacked bullishly on shorter timeframes; The 27.6% rally off June lows was a real recovery; TTM EPS of $8.63 and actual Q1 FY27 earnings did print as reported; The MACD has turned positive from deeply oversold levels; S&M reinvestment could ultimately drive revenue growth if AI monetization scales
→ vs conservative: Conservative's 8% downside estimate is wrong — real structural support sits at $154-160, not the 50 SMA at $171, making the actual risk/reward 1:2 not 1:1
→ vs conservative: Conservative ignores the FCF math on leveraged buybacks: borrowing at 5% to generate 8%+ FCF yield is value creation, not financial engineering
→ vs conservative: Conservative's balance sheet concerns ignore $16.5B annual FCF, 7.6x interest coverage, and investment-grade debt issuance terms
→ vs neutral: Neutral's patience/HOLD thesis conflates discipline with opportunity cost — every historical software setup that required confirmed breakouts saw 30-50% moves occur before confirmation
→ vs conservative: Conservative treating AI catalysts as 'background color' ignores that VA contract is a 3-year recurring revenue agreement and IL5 authorization is a regulatory moat
→ vs conservative: Conservative completely ignores technicals — 200 SMA at $203 is a time function, not price function; consolidation before next leg up is normal
Market Cap
$153.0 B
Current Price
~$186.78
52-Week High
$269.11
52-Week Low
$146.32
50-Day Moving Average
$171.14
200-Day Moving Average
$204.78
Beta
1.152
TTM P/E
21.64
Forward P/E
12.04
PEG Ratio
0.76
Price / Book
4.47
Dividend Yield
0.95%
EPS (TTM)
$8.63
EPS (Forward Est.)
$15.51
TTM Revenue
$42.83 B
TTM Gross Profit
$33.25 B
TTM EBITDA
$12.89 B
TTM Net Income
$8.02 B
TTM Gross Margin
77.6%
TTM Operating Margin
21.8%
TTM Net Margin
18.7%
TTM ROE
16.9%
TTM ROA
5.7%
TTM Free Cash Flow
$16.55 B
TTM CapEx
~$0.56 B
TTM Stock-Based Comp
~$3.6 B
Total Assets
$106.7 B
Cash & ST Investments
$11.84 B
Long-Term Debt
$39.28 B
Total Debt
$41.88 B
Net Debt
$30.35 B
Stockholders' Equity
$34.24 B
Goodwill & Intangibles
$65.94 B
Tangible Book Value
$(31.71) B
Current Ratio
0.786
Debt / Equity
1.22x
Q1 FY27 Revenue
$11.13 B
Q1 FY27 Gross Profit
$8.56 B
Q1 FY27 Operating Income
$2.43 B
Q1 FY27 Net Income
$2.11 B
Q1 FY27 EPS (Diluted)
$2.42
Q1 FY27 Free Cash Flow
$6.56 B
Q1 FY27 Buybacks
$27.25 B
Q1 FY27 LT Debt Issued
$24.84 B
Q1 FY27 Operating CF
$6.70 B
Q1 FY27 CapEx
$145 M
Interest Coverage
~7.6x
Current Deferred Revenue
$20.4 B
Diluted Shares Outstanding
871M
Book Value Per Share
$41.80
Strengths
Concerns
Salesforce is transitioning from a post-activist "show me" story back to a growth-plus-return-of-capital narrative, with Q1 FY27 delivering the strongest fundamental combination in years: 13.3% revenue growth re-acceleration, 21.8% operating margins expanding, and $16.55B TTM FCF funding one of the largest buyback programs ever. The $27.25B leveraged buyback in Q1 FY27 is mathematically EPS-accretive but raises equity sensitivity risk given $30.35B net debt, though interest coverage of 7.6x and >$12B TTM EBITDA suggest solvency is not threatened. Valuation has reset to attractive levels (Forward P/E 12.04, PEG 0.76) for a quality software franchise, making execution on Agentforce/AI the key swing factor for re-rating.